Maediastinal germ cell tumors: analysis using hospital-based cancer registry data in Japan

Int J Clin Oncol. 2024 Nov;29(11):1756-1761. doi: 10.1007/s10147-024-02607-y. Epub 2024 Sep 5.

Abstract

Objectives: Mediastinal germ cell tumors are rare and few large-scale studies on mediastinal germ cell tumors are reported. We aimed to investigate the clinical characteristics and survival outcomes of patients with mediastinum germ cell tumors in Japan.

Methods: A hospital-based cancer registry data in Japan was used to identify and enroll patients diagnosed with mediastinal germ cell tumors in 2012-2013. The datasets were registered from 80 institutions.

Results: The selection criteria were met by 123 patients, the majority of whom were male. The median age at diagnosis was 39 years (range 25-89 years) and the most common age groups at diagnosis was 30-39 years, followed by 40-49 years and ≥ 50 years. The histology of non-seminoma (55.3%) was slightly more frequent than that of seminoma (44.7%). The most common histological subtype in non-seminoma was yolk sac tumor, followed by mixed germ cell tumor. The 5-year survival of seminoma and non-seminoma were 96.4% and 57.3%, respectively (p < 0.001). Non-seminomatous mediastinal germ cell tumors, malignant teratomas, mixed germ cell tumors, and yolk sac tumors had comparable survival rates, while those with choriocarcinoma showed the worst prognosis.

Conclusions: This is the first report showing the clinical characteristics and survival outcomes of mediastinal germ cell tumors in Japan using a real-world large cohort database.

Keywords: Hospital-based cancer registry; Mediastinal germ cell tumor; Non-seminoma; Seminoma.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Humans
  • Japan / epidemiology
  • Male
  • Mediastinal Neoplasms* / epidemiology
  • Mediastinal Neoplasms* / mortality
  • Mediastinal Neoplasms* / pathology
  • Middle Aged
  • Neoplasms, Germ Cell and Embryonal* / epidemiology
  • Neoplasms, Germ Cell and Embryonal* / mortality
  • Neoplasms, Germ Cell and Embryonal* / pathology
  • Registries*
  • Seminoma / epidemiology
  • Seminoma / mortality
  • Seminoma / pathology
  • Survival Rate